About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Betamethasone
- Procedure number
- PSUSA/00000391/202101
- Regulatory outcome
- Variation
Documents
Betamethasone : List of nationally authorised medicinal products - PSUSA/00000391/202101
English (EN) (403.76 KB - PDF)
Betamethasone : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000391/202101
English (EN) (156.56 KB - PDF)
български (BG) (126.38 KB - PDF)
español (ES) (157.21 KB - PDF)
čeština (CS) (411.72 KB - PDF)
dansk (DA) (156.89 KB - PDF)
Deutsch (DE) (107.8 KB - PDF)
eesti keel (ET) (150.55 KB - PDF)
ελληνικά (EL) (126.78 KB - PDF)
français (FR) (192.49 KB - PDF)
hrvatski (HR) (218.18 KB - PDF)
íslenska (IS) (125.77 KB - PDF)
italiano (IT) (123.46 KB - PDF)
latviešu valoda (LV) (165.6 KB - PDF)
lietuvių kalba (LT) (429.9 KB - PDF)
magyar (HU) (215.99 KB - PDF)
Malti (MT) (90.56 KB - PDF)
Nederlands (NL) (135.15 KB - PDF)
norsk (NO) (182.53 KB - PDF)
polski (PL) (206.42 KB - PDF)
português (PT) (156.53 KB - PDF)
română (RO) (130.4 KB - PDF)
slovenčina (SK) (125.51 KB - PDF)
slovenščina (SL) (198.26 KB - PDF)
Suomi (FI) (113.87 KB - PDF)
svenska (SV) (175.82 KB - PDF)